<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2393-6797</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Medicina Interna ]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Urug. Med. Int.]]></abbrev-journal-title>
<issn>2393-6797</issn>
<publisher>
<publisher-name><![CDATA[Sociedad de Medicina Interna del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2393-67972022000300044</article-id>
<article-id pub-id-type="doi">10.26445/07.03.4</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Utilidad del MoCA (Montreal Cognitive Assessment) como test de cribado para el deterioro cognitivo leve en población de hipertensos.]]></article-title>
<article-title xml:lang="en"><![CDATA[Usefulness of the MoCA (Montreal Cognitive Assessment) as a screening test for mild cognitive impairment in the hypertensive population.]]></article-title>
<article-title xml:lang="pt"><![CDATA[Utilidade do MoCA (Montreal Cognitive Assessment) como teste de triagem para comprometimento cognitivo leve na população hipertensa]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Spósito]]></surname>
<given-names><![CDATA[Paola]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Llorens]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Clínica Médica 3]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2022</year>
</pub-date>
<volume>7</volume>
<numero>3</numero>
<fpage>44</fpage>
<lpage>52</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S2393-67972022000300044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S2393-67972022000300044&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S2393-67972022000300044&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  La demencia es una enfermedad prioritaria en los servicios de salud de países en vías de desarrollo. El 30% de los pacientes hipertensos sin compromisos de otros órganos presentan daño vascular encefálico y deterioro de las funciones cognitivas. Es importante por tanto contar con test de tamizaje adecuado.  Objetivos:  Evaluar el status cognitivo en pacientes hipertensos utilizando en forma sistemática el test de MoCA. Evaluar la sensibilidad y especificidad del mismo y determinar el punto de corte óptimo para detectar deterioro cognitivo leve (DCL).  Metodología:  Estudio analítico observacional de corte transversal. Criterios de Inclusión. Pacientes mayores de 18 años, asistidos en la policlínica de hipertensión arterial del Hospital Maciel (2017- 2021). Criterios de Exclusión. Dificultades motoras, sensoriales, enfermedad psiquiátrica severa, analfabetismo.  Resultados:  Se incluyeron 137 pacientes con evaluación cognitiva La edad media 60,4 ± 12,5 91(66,4%) de sexo femenino. 103 (77,4%) Hipertensión arterial grado 3. Se detectaron 19 pacientes con DCL (13.9%) y 1 con demencia (0.7%). La mediana de puntuación del MoCA en el grupo sin DCL fue de 26 y de 21.5 en el grupo con DCL (p = 0.0001). Con un punto de corte de 26 el test de MoCA resultó alterado en 63 pacientes (49.5%), con una sensibilidad de 100% y especificidad de 58.7%. El valor predictivo positivo (VPP) fue de 28.6% y valor predictivo negativo (VPN) de 100%. Con el descenso del punto de corte a 24, se logró el mejor balance entre sensibilidad y especificidad (88,9% y 78,9%) respectivamente. El VPP de 41,0% y VPN de 97,7%. En todos los pacientes el DCL fue de tipo multidominio. Se encontraron diferencias significativas en todos los dominios cognitivos, especialmente la función ejecutiva.  Conclusiones:  En nuestro estudio el test de MoCA se muestra como un instrumento de gran utilidad para detectar DCL. El punto de corte óptimo para detectar DCL en esta población de hipertensos es 24.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  Dementia is a priority disease in the health systems of developing countries. 30% of hypertensive patients without compromise of other organs present encephalic vascular damage and deterioration of cognitive functions. It is therefore important to have an adequate screening test.  Objectives:  To evaluate cognitive status in hypertensive patients systematically using the MoCA test. Evaluate its sensitivity and specificity and determine the optimal cut-off point to detect mild cognitive impairment (MCI).  Methodology:  Cross-sectional observational analytical study. Inclusion criteria. Patients over 18 years of age, attended at the High blood pressure (HBP) polyclinic of Hospital Maciel (2017-2021). Exclusion criteria. Motor and sensory difficulties, severe psychiatric illness, illiteracy.  Results:  137 patients with cognitive evaluation were included. Mean age 60.4 ± 12.5 91 (66.4%) female. 103 (77.4%) HBP grade 3, 19 patients with (MCI) (13.9%) and 1 with dementia (0.7%) were detected. The median MoCA score in the group without MCI was 26 and 21.5 in the group with MCI (p =0.0001). With a cut-off point of 26, the MOCA test was altered in 63 patients (49.5%) with a sensitivity of 100% and a specificity of 58.7%. The positive predictive value (PPV) was 28.6% and the negative predictive value (NPV) was 100%. By lowering the cut-off point to 24, the best balance between sensitivity and specificity was achieved (88.9% and 78.9%), respectively. The PPV of 41.0% and VPN of 97.7%. In all patients, the MCI was of the multidomain type. Significant differences were found in all cognitive domains, especially executive function.  Conclusions:  In our study, the MoCA test is shown to be a very useful instrument to detect MCI.The optimal cut-off point to detect MCI in this hypertensive population is 24.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução: A demência é uma doença prioritária nos sistemas de saúde dos países em desenvolvimento. 30% dos hipertensos sem envolvimento de outros órgãos apresentam lesão vascular encefálica e deterioração das funções cognitivas. Portanto, é importante ter um teste de triagem adequado.  Objetivos:  Avaliar o estado cognitivo em pacientes hipertensos sistematicamente por meio do teste MoCA. Avalie sua sensibilidade e especificidade e determine o ponto de corte ideal para detectar CCL.  Metodologia:  Estudo analítico observacional transversal. Critérios de incluso. Pacientes maiores de 18 anos, atendidos na policlínica hipertensão arterial do Hospital Maciel (2017-2021). Critérios de exclusão. Dificuldades motoras e sensoriais, doença psiquiátrica grave, analfabetismo.  Resultados:  Foram incluídos 137 pacientes com avaliação cognitiva, idade média 60,4 +/- 12,5 91 (66,4%) do sexo feminino, 103 (77,4%) hipertensão arterial grau 3. 19 pacientes com comprometimento cognitivo leve (CCL) (13,9%) e 1 com demência (0,7%) foram detectados. A mediana do escore MOCA no grupo sem DCL foi de 26 e 21,5 no grupo com DCL (p=0,0001). Com ponto de corte de 26, o teste MOCA foi alterado em 63 pacientes (49,5%) com sensibilidade de 100% e especificidade de 58,7%. O valor preditivo positivo (VPP) foi de 28,6% e o valor preditivo negativo (VPN) foi de 100%. Ao diminuir o ponto de corte para 24, obteve-se o melhor equilíbrio entre sensibilidade e especificidade (88,9% e 78,9%), respectivamente. O PPV de 41,0% e VPN de 97,7%. Em todos os pacientes, o CCL foi do tipo multidomínio. Diferenças significativas foram encontradas em todos os domínios cognitivos, especialmente na função executiva.  Conclusões:  Em nosso estudo, o teste MoCA mostrase um instrumento muito útil para detectar CCL. O ponto de corte ideal para detectar CCL nesta população hipertensa é 24.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[test de cribado]]></kwd>
<kwd lng="es"><![CDATA[deterioro cognitivo leve]]></kwd>
<kwd lng="es"><![CDATA[Hipertensión arterial]]></kwd>
<kwd lng="en"><![CDATA[screening test]]></kwd>
<kwd lng="en"><![CDATA[mild cognitive impairment]]></kwd>
<kwd lng="en"><![CDATA[High blood pressure]]></kwd>
<kwd lng="pt"><![CDATA[teste de triagem]]></kwd>
<kwd lng="pt"><![CDATA[comprometimento cognitivo leve]]></kwd>
<kwd lng="pt"><![CDATA[hipertensão arterial]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gangulli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factores de riesgo de demencia en la vejez modificable en las etapas de la vida]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2005</year>
<volume>51</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>259-62</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalaria]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Maestre]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Arizaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Friedland]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Galasko]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alzheimers disease and vascular dementis in developing countries Prevalence, management, and risk factors]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2008</year>
<volume>7</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>812-26</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lorenzo Otero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Fontán Scheitler]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las fronteras entre el envejecimiento normal y la enfermedad de Alzheimer El concepto de deterioro cognitivo leve]]></article-title>
<source><![CDATA[Rev Med Urug]]></source>
<year>2003</year>
<volume>19</volume>
<page-range>4-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalmás]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuropsicología de la memoria: en La memoria desde la Neuropsicología]]></source>
<year>1993</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Roca viva]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Waring]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mild cognitive impairment Clinical. characterization and outcome]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>1999</year>
<volume>56</volume>
<page-range>303-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Serrano]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dillon]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taragano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Allegri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deterioro cognitivo leve riesgo de demencia según subtipos]]></article-title>
<source><![CDATA[Actas Esp Psiquiatr]]></source>
<year>2013</year>
<volume>41</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>330-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicario]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Del Sueldo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Enders]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zilberman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cerezo]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cognition and vascular risk factors an epidemiological study]]></article-title>
<source><![CDATA[Int J Hypertens]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>783696</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yaffe]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Vittinghoff]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pletcher]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hoang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Launer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early adulto to midlife cardiovascular risk factors and cognitive function]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2014</year>
<volume>129</volume>
<page-range>1560-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gasecki]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kwarciany]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nyka]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Narkiewicz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hypertension, brain damage and cognitive decline]]></article-title>
<source><![CDATA[Curr Hypertens Rep]]></source>
<year>2013</year>
<volume>15</volume>
<page-range>547-58</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lane]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nicholas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46) an epidemiological study]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2019</year>
<volume>18</volume>
<page-range>942-52</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicario]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cerezo]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Why Should We Must Evaluate Cognitive Function in Hypertensive Patients]]></article-title>
<source><![CDATA[Brain Disord Ther]]></source>
<year>2021</year>
<volume>10</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Grupo de Trabajo de la Sociedad Europea de Cardiología</collab>
<collab>European Society of Hypertension</collab>
<article-title xml:lang=""><![CDATA[Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2019</year>
<volume>72</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>160</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scuteri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Benetos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coca]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chicherio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Frisoni]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians why and how-a decision-making support from the working group on &amp;apos;hypertension and the brain&amp;apos; of the European Society of Hypertension and from the European Geriatric Medicine Society]]></article-title>
<source><![CDATA[J Hypertens]]></source>
<year>2021</year>
<volume>39</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>90-100</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gildeh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Holmes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Montreal Cognitive Assesment: validity and utility in memory clinic setting]]></article-title>
<source><![CDATA[Can J Psiquiatry]]></source>
<year>2007</year>
<volume>52</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>329-32</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lozano Gallego]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández Ferrándiz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Turró Garriga O Validación del Montreal cognitive assessment (MOCA): test de cribado para el deterioro cognitivo leve. Datos preliminares]]></article-title>
<source><![CDATA[Alzheimer Real Invest Demenc]]></source>
<year>2009</year>
<volume>43</volume>
<page-range>4-11</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Simões]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Ponciano]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Santana]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation studies of the Portuguese experimental version of the Montreal Cognitive Assessment (MoCA) confirmatory factor analysis]]></article-title>
<source><![CDATA[J Neurol]]></source>
<year>2010</year>
<volume>257</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>728-34</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sarmento]]></surname>
</name>
<name>
<surname><![CDATA[AL Rosas]]></surname>
</name>
<name>
<surname><![CDATA[Bertolucci]]></surname>
</name>
<name>
<surname><![CDATA[PH Ferreira]]></surname>
</name>
</person-group>
<source><![CDATA[Apresentação e aplicabilidade da versão brasileira da MoCA (Montreal Cognitive Assessment )para rastreio de Comprometimento Cognitivo Leve 2009 82 f Dissertação (Mestrado)]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Universidade Federal de São Paulo(UNIFESP) ]]></publisher-loc>
<publisher-name><![CDATA[São Paulo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Kwan]]></surname>
<given-names><![CDATA[PWL]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[AYY]]></given-names>
</name>
<name>
<surname><![CDATA[Lam]]></surname>
<given-names><![CDATA[WWM]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Validity, Reliability and Clinical Utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in Patients with Cerebral Small Vessel Disease]]></article-title>
<source><![CDATA[Dement Geriatr Cogn Disord]]></source>
<year>2009</year>
<volume>28</volume>
<page-range>81-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Na]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Jeon]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kyum Kim]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Brief Screening for Mild Cognitive Impairment in Elderly Outpatient Clinic Validation of the Korean Version of the Montreal Cognitive Assessment]]></article-title>
<source><![CDATA[J geriatr. psychiatr. neurol]]></source>
<year>2008</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>104-10</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karunaratne]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hanwella]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[de Silva]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Sinhala version of the Montreal Cognitive Assessment in screening for dementia]]></article-title>
<source><![CDATA[Ceylon Medical Journal]]></source>
<year>2011</year>
<volume>56</volume>
<page-range>147-53</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasreddine]]></surname>
<given-names><![CDATA[ZS]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Bédirian]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Charbonneau]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Whitehead]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Collin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Montreal Cognitive Assessment, MoCA a brief screening tool for mild cognitive impairment]]></article-title>
<source><![CDATA[J Am Geriatr Soc]]></source>
<year>2005</year>
<volume>53</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>695-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Saracco-Álvarez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Escamilla-Orosco]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Fresán]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validez de la escala de evaluación cognitiva de Montreal (MoCA) para determinar deterioro cognitivo en pacientes con esquizofrenia]]></article-title>
<source><![CDATA[Salud Mental]]></source>
<year>2014</year>
<volume>37</volume>
<page-range>517-22</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luis]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Keegan]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Mullan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US]]></article-title>
<source><![CDATA[Int J Geriatr Psychiatry]]></source>
<year>2009</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>197-201</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McLennan]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Mathias]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Brennan]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population]]></article-title>
<source><![CDATA[J Geriatr Psychiatry Neurol]]></source>
<year>2011</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williamson]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Pajewski]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Auchus]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Bryan]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Chelune]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<collab>Investigators for the SPRINT Research Group</collab>
<article-title xml:lang=""><![CDATA[Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia A Randomized Clinical Trial]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2019</year>
<volume>321</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>553-61</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Waring]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Ivnik]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kokmen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Tangelos]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aging, memory, and mild cognitive impairment]]></article-title>
<source><![CDATA[Int Psychogeriatr]]></source>
<year>1997</year>
<volume>9</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>65-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Doody]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kurz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mohs]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Morris]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Rabins]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current concepts in mild cognitive impairment]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2001</year>
<volume>58</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1985-92</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
